Prostatic ductal adenocarcinoma: An aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI)

European Radiology

Volumn 24, Issue 6, 2014, Pages 1349-1356

  Schieda, Nicola ^a   Coffey, Niamh ^a   Gulavita, Previn ^a   Al Dandan, Omran ^a   Shabana, Wael ^a   Flood, Trevor A ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Active surveillance; Ductal adenocarcinoma; Gleason score and grade; Magnetic resonance imaging; Prostate cancer

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBTURATOR INTERNUS MUSCLE; PELVIS; PERIPHERAL ZONE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; PROSTATIC DUCTAL ADENOCARCINOMA; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; AGED; CARCINOMA, DUCTAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; PREOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84901682375     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3150-9     Document Type: Article

References (42)

1. Dube VE, Farrow GM, Greene LF (1973) Prostatic adenocarcinoma of ductal origin. Cancer 32:402-409
2. Bostwick DG, Kindrachuk RW, Rouse RV (1985) Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol 9:595-609 (Pubitemid 16220660)
3. Brinker DA, Potter SR, Epstein JI (1999) Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression.Am J Surg Pathol 23:1471-1479
4. Epstein JI, Woodruff JM (1986) Adenocarcinoma of the prostatewith endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer 57:111-119 (Pubitemid 16212244)
5. Lemberger RJ, Bishop MC, Bates CP, BlundellW, Ansell ID (1984) Carcinoma of the prostate of ductal origin. Br J Urol 56:706-709 (Pubitemid 15187560)
6. Orihuela E, Green JM (2008) Ductal prostate cancer: contemporary management and outcomes. Urol Oncol 26:368-371 (Pubitemid 351885371)
7. Humphrey PA (2012) Histological variants of prostatic carcinoma and their significance. Histopathology 60:59-74
8. Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL (2010) Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol 184:2303-2307
9. Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24:S167-S180 (Pubitemid 39457252)
10. Jung AJ, Westphalen AC (2012) Imaging prostate cancer. Radiol Clin N Am 50:1043-1059
11. Soylu FN, Eggener S, Oto A (2012) Local staging of prostate cancer with MRI. Diagn Interv Radiol 18:365-373
12. HaiderMA, van der Kwast TH, Tanguay J et al (2007) Combined T2- weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323-328 (Pubitemid 47195916)
13. LimHK, Kim JK, Kim KA, Cho KS (2009) Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection - a multireader study. Radiology 250:145-151
14. Mazaheri Y, Hricak H, Fine SW et al (2009) Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 252:449-457
15. Vargas HA, Akin O, Franiel T et al (2011) Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 259:775-784
16. Futterer JJ, Heijmink SW, Scheenen TWet al (2006) Prostate cancer localization with dynamic contrast-enhancedMRimaging and proton MR spectroscopic imaging. Radiology 241:449-458 (Pubitemid 44632891)
17. Delongchamps NB, RouanneM, FlamTet al (2011)Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107:1411-1418
18. Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA (2009) Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30:327-334
19. Turkbey B, Pinto PA, Mani H et al (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection-histopathologic correlation. Radiology 255:89-99
20. Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K (2010) Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging 31:625-631
21. Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746-757
22. Stamatakis L, Siddiqui MM, Nix JW et al (2013) Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer 119:3359-3366
23. Turkbey B, Mani H, Aras O et al (2013) Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268:144-152
24. Hoeks CM, Hambrock T, Yakar D et al (2013) Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 266:207-217
25. Westphalen AC, Rosenkrantz AB (2014) Prostate Imaging Reporting and Data System (PI-RADS): reflections on early experience with a standardized interpretation scheme formultiparametric prostateMRI. AJR Am J Roentgenol 202:121-123
26. Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H (2008) Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology 246:168-176 (Pubitemid 350305040)
27. Network NCC (2012) Clinical practice guidelines in oncology: prostate cancer. National Comprehensive Cancer network, Fort Washington, PA. http://www.nccn.com/files/cancer-guidelines/prostate/index.html#/1. Accessed 13 Sep 2013
28. Hegde JV, Mulkern RV, Panych LP et al (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37:1035-1054
29. Kvale R, Moller B, Wahlqvist R et al (2009) Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int 103:1647-1654
30. Rabbani F, Stroumbakis N, Kava BR, CooksonMS, FairWR (1998) Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 159:1247-1250 (Pubitemid 28172807)
31. Beddy P, O'Neill AC, Yamamoto AK, Addley HC, Reinhold C, Sala E (2012) FIGOstaging system for endometrial cancer: added benefits of MR imaging. Radiographics 32:241-254
32. Heidenreich A, Bastian PJ, Bellmunt J et al (2012) Guidelines on prostate cancer. European Association of Urology, Arnhem, the Netherlands. http://www.uroweb.org/gls/pdf/08%20Prostate%20Cancer-LR%20March%2013th%202012. pdf. Accessed 13 Sep 2013
33. JacksonW, Hamstra DA, Johnson S et al (2013) Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy. Cancer 119:3287-3294
34. Mosse CA, Magi-Galluzzi C, Tsuzuki T, Epstein JI (2004) The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol 28:394-398 (Pubitemid 38269575)
35. Kulkarni MV, Patton JA, Price RR (1986) Technical considerations for the use of surface coils in MRI. AJR Am J Roentgenol 147:373-378 (Pubitemid 16066853)
36. Meeks JJ, Zhao LC, Cashy J, Kundu S (2012) Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program. BJU Int 109:831-834
37. Epstein JI, AllsbrookWC Jr, AminMB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228-1242 (Pubitemid 41232997)
38. Hoeks CM, Barentsz JO, Hambrock T et al (2011) Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 261:46-66
39. Langer DL, van der Kwast TH, Evans AJ et al (2010) Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology 255:485-494
40. Kim BS, Kim TH, Kwon TG, Yoo ES (2012) Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer. Yonsei Med J 53:550-556
41. Eberhardt SC, Carter S, Casalino DD et al (2013) ACR appropriateness criteria prostate cancer - pretreatment detection, staging, and surveillance. J Am Coll Radiol 10:83-92
42. Bratan F, Niaf E, Melodelima C et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23:2019-2029